CFG
36
12
WBA
41
3
IRM
33
5
WU
26
2
ROP
44
6
PWR
63
3
HAL
40
11
AMAT
33
3
BMY
40
-5
EOG
28
2
MDLZ
28
2
COP
36
2
MTB
38
4
RCL
74
5
MS
64
3
GE
60
5
AMGN
42
14
SNA
56
3
CTSH
55
3
HSY
32
3
CFG
36
12
WBA
41
3
IRM
33
5
WU
26
2
ROP
44
6
PWR
63
3
HAL
40
11
AMAT
33
3
BMY
40
-5
EOG
28
2
MDLZ
28
2
COP
36
2
MTB
38
4
RCL
74
5
MS
64
3
GE
60
5
AMGN
42
14
SNA
56
3
CTSH
55
3
HSY
32
3
Financhill
Back

Jazz Pharmaceuticals PLC 10K Form

Buy
57

JAZZ
Jazz Pharmaceuticals PLC

Last Price:
$122.89
Seasonality Move:
9.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-02 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2023-11-08 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2023-08-09 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2023-05-10 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2022-11-09 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2022-08-03 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly

Receive JAZZ News And Ratings

See the #1 stock for the next 7 days that we like better than JAZZ

JAZZ Financial Statistics

Sales & Book Value

Annual Sales: $3.8B
Cash Flow: $388M
Price / Cash Flow: 7.4
Annual Sales: $69.01
Price / Book: 1.78

Profitability

EPS (TTM): 7.10000
Net Income (TTM): $463.2M
Gross Margin: $3.4B
Return on Equity: 12.28%
Return on Assets: 4.03%

Jazz Pharmaceuticals PLC Earnings Forecast

Key Jazz Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 19 years for JAZZ is 88.64%.
  • The Selling, General & Administrative Expenses for JAZZ have been equal to 35.03% of Gross Profit Margin.
  • The Research & Development expenses have been 22.16% of Revenue.
  • The Interest Expense is 69.77% of Operating Income.
  • The Net Earning history of JAZZ is 10.82% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Jazz Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: JAZZ
CUSIP: G50871
Website: jazzpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 1.47
Current Ratio: 4.26
Quick Ratio: 3.24

Price-to-Earnings

Trailing P/E Ratio: 20.16
Forward P/E Ratio: 5.64

JAZZ Technical Analysis vs Fundamental Analysis

Buy
57
Jazz Pharmaceuticals PLC (JAZZ) is a Buy

Is Jazz Pharmaceuticals PLC a Buy or a Sell?